Abstract:Background: Benign prostatic hyperplasia (BPH) is a common chronic progressive disease resulting in urinary obstruction in aging men. It comes to more and more patients with massive BPH with the aging of society and extension of life expectancy. Objective: The aim of the study was to compare the clinical efficacy, safety, and complications between transurethral bipolar plasmakinetic enucleation of the prostate (PKEP) and transurethral resection of the prostate (TURP) in the treatment of massive BPH. Design and setting: Patients with BPH were divided into the PKEP group and the TURP group randomly. Intraoperative blood loss (BL), operation time (OT), resected tissue weight (RTW), gland resection ratio (GRR), postoperative indwelling ureter time (IUT), bladder fistula time (BFT) and hospital stay time (HST), preoperative and postoperative serum sodium concentration (SSC), hemoglobin concentration (HGB), prostate weight (PW), postvoid residual (PVR), maximum urinary flow rate (Qmax), international prostate symptom score (IPSS), quality of life (QOL), International Index of Erectile Function (IIEF), and other complications were analyzed and compared respectively. Results: There was no statistical difference in preoperative IPSS, preoperative QOL score, preoperative PVR, preoperative Qmax, postoperative QOL score, postoperative PVR, postoperative Qmax, IPSS difference value (DV), Qmax DV, and PVR DV between the PKEP group and the TURP group (p > 0.05). OT, BL, IUT, BFT, HST, and postoperative IPSS in the PKEP group were significantly lower than that in the TURP group (p < 0.01). RTW and GRR in the PKEP group were significantly higher than that in the TURP group (p < 0.01). QOL DV in the PKEP group was higher than that in the TURP group (p < 0.05). There was statistical difference in SSC DV between the PKEP group and the TURP group (p < 0.05). There was significant statistical difference in postoperative PW, postoperative HGB, PW DV, and HGB DV between the PKEP group and the TURP group (p < 0.01). There was significant statistical difference in IPSS, QOL, PVR, and Qmax between postoperative value and preoperative value in both groups (p < 0.01). The incidence of transurethral resection syndrome, obturator nerve reflex, transient urinary incontinence, and retrograde ejaculation between the PKEP group and the TURP group has no statistical difference (p > 0.05). Capsule perforation, blood transfusion, secondary hemorrhage, bladder neck contracture, and urethral stricture in the PKEP group were lower than that in the TURP group (p < 0.05). Bladder spasm in the PKEP group was significantly lower than that in the TURP group (p < 0.01). There was no statistical difference in preoperative and postoperative IIEF-5, effective erectile frequency, telotism average tension, sustainable telotism average time, and sexual dissatisfaction between the PKEP group and the TURP group (p > 0.05). Conclusions: PKEP and TURP have similar clinical efficacy in the treatment of massive BPH. PKEP has advantages in shorter OT, less BL, more GRR, and fewer complications, but the long-term therapeutic effect of PKEP needs further follow-up.

Comparison of transurethral plasmakinetic resection of the prostate and transvesical prostectomy for the treatment of large volume benign prostatic hyperplasia

Comparison of transurethral plasmakinetic and transvesical prostatectomy in treatment of 100-149 mL benign prostatic hyperplasia.

Comparative Analysis of the Efficacy and Safety of Transurethral Plasmakinetic Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia of Different Volumes

A Comparative Study of Transurethral Plasmakinetic Resection Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

The Clinical Safety and Efficacy of PKRP and TURP in the Treatment of Patients with Benign Prostatic Hyperplasia Prostate(volume>60 Ml):A Compared Study

Comparative Study of the Effectiveness and Safety of Transurethral Bipolar Plasmakinetic Enucleation of the Prostate and Transurethral Bipolar Plasmakinetic Resection of the Prostate for Massive Benign Prostate Hyperplasia (>80 ml)

Comparison of efficacy and safety between transurethral plasma kinetic resection of prostate and conventional transurethral resection of prostate for treatment of benign prostate hyperplasia

Two-year Outcome of High-risk Benign Prostate Hyperplasia Patients Treated with Transurethral Prostate Resection by Plasmakinetic or Conventional Procedure

Comparison of efficacy and safety between transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics

Prospective study of transurethral plasma kinetic enucleation of prostate versus suprapubic prostatectomy for benign prostatic hyperplasia greater than 100 grams

Transurethral Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia

Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia

Transurethral bipolar plasmakinetic resection combined with 2 μm laser vaporization in the treatment of larger-volumed benign prostate hyperplasia

Short-term efficacy comparison between TUVRP and PKRP for treatment of patients with LUTS suggestive of BPH

The Effectiveness And Safety Of Transurethral (Bipolar) Plasmakinetic Resection Of Prostate Combined With Thulium Laser For Large Benign Prostatic Hyperplasia (> 80ml)

Plasmakinetic vaporization for treatment of large volume benign prostatic hyperplasia

An evaluation of transurethral plasma kinetic resection versus transurethral resection of the prostate for the treatment of symptomatic BPH

Transurethral Plasmakinetic Resection Versus Enucleation for Benign Prostatic Hyperplasia: Comparison of Intraoperative Safety Profiles Based on Endoscopic Surgical Monitoring System

[Transurethral Plasmakinetic Enucleation of the Prostate for Benign Prostatic Hyperplasia].

Five-Year Follow-Up Study of Transurethral Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia.